Investing in Italian
digital economy
2nd German – ItalianInnovation Conference
21st November 2018, Berlin

Investing in Italian digital economy
2nd German – Italian Innovation Conference
Lombardy

Aosta Valley

Friuli-Venezia Giulia

Emilia-Romagna

Lazio
Tuscany
ApuliaSardinia

Calabria

DIGITAL HEALTH(Business projects)
SMART MOBILITY& LOGISTICS (Business projects)

DIGITAL CONTENTS& CREATIVE INDUSTRIES (Business projects)

DIGITAL ECONOMY& SMART MANUFACTURING (Innovation hubs)

2

FOCUSDIGITAL HEALTH(Business projects)

SMART MOBILITY& LOGISTICS(Business projects)

DIGITAL
CONTENTS& CREATIVEINDUSTRIES(Business projects)
DIGITALECONOMY& SMART
MANUFACTURING(Innovation hubs)

REGION

BUSINESS OPPORTUNITY

Page

ApuliaCAREPY

6

Calabria

Breathless: screening test of lung injury

7

Calabria

MATE (Multifunction Assistant fo liTtle kids and theElderly)8

Calabria

SleepAnalyzer

9Calabria

TremorAnalyzer

10

Lazio

ABILITA: a mobile application to support disabled,elderly and complex (health)care populations

11

Lazio

Aenduo Biometrical IOT

12

Lazio

ASSIOMA PROJECT

13

Lazio

MRT-DSS (MOLECULAR RADIO THERAPY-DECISIONSUPPORT SYSTEM)

14

Lazio

FILO BLU System

15

Lazio

HA-R2EC

16

Lazio

Integrated health care pathway for patients with severe
acquired brain injury

17

Lazio

LIFESEEDER and LIFELAB

18

Lazio

Platform for early and non-invasive diagnostics ofneurodegenerative diseases

19

Lazio

TraiNurse – From an Industrial Research Project toCommercial Development

22

Sardinia

TPM - Total Patient Management

23

Tuscany

BRAINCONTROL

24

ApuliaNEXTOME – Indoor Navigation, Indoor Positioning andIndoor Tracking system

28

Calabria

Rail Transport System with Convoys Automatic
Composition

29

Lazio

Pickmeup

30

Lazio

Certified Zero Emission Last-mile Delivery

32

Aosta Valley

Q-CAST - Interactive real-time multi-streaming solutions
for one-to-million communication

36

ApuliaD4D (Digital 4 Democracy)

37

Lazio

OLOS®

39

Emilia-Romagna

BIG DATA TECHNOPOLE- BOLOGNA HUB

42

Friuli-Venezia Giulia

Additive FVG Square

44

Friuli-Venezia Giulia

Development of a platform devoted to Artificial
Intelligence for manufacturing companies’ innovation

45

Lombardy

MIND (Milano Innovation District)46

3

Project Coordination
Ufficio Partenariato e Analisi Settoriali per gli Investimenti Esteri:Stefano Nigro
Gruppo di lavoro integrato ICE Agenzia – Invitalia:
Elisabetta Merlino, Marco D’Acunto, Antonella Keller
Graphic Design & Layout
Ufficio di Coordinamento Promozione del Made in Italy:
Irene Caterina Luca, Vincenzo Lioi, Giovanni Beccu

5

REGIONE PUGLIAAPULIA | CAREPY

Proposer: CAREPY
Sector: ICT/ HEALTH CARE

Focus:PROJECT DESCRIPTION

We looked to a very common problem in Europe: the low patient complianceand the lack of management of drugs and health products at home. More thanhalf of European patients do not take proper care of themselves, not adequately
following their treatment plans and medical treatments, skipping and confusing the
medications prescribed by the doctor or not knowing what products are present at
home.
This causes serious consequences on the patients’ health, which will be then require
longer and more expensive recovery interventions.
The additional expenses that European health systems have due to lack of patientcompliance, amount to about 125 billion euros a year, 1/7 of the total cost of publichealth.
Carepy provides patients with a digital health assistant through a mobile app thatalerts users for taking medication, taking measures, keeping an appointment or goingback to a pharmacy. It also provides personalized advice and promotions.
Among the main advantages of Carepy there is the possibility of establishing a directchannel of communication for people, their pharmacy and the doctor, proactively
supporting therapeutic adherence and monitoring the levels of individual drugs,
without impacting pharmacy or medical practice daily activities and internal
resources.
In addition, the pharmacist will be able to manage targeted promotion activities
on individual or groups of patients segmented along multiple criteria and promote
specific products or initiatives by the pharmacy through the mobile app or via SMS.

CONTACT INFOPUGLIA SVILUPPO

Carepy is also used by healthcare facilities, where specialist doctors can follow thetreatment cycle in real time and improve the patient compliance of patients during
de-hospitalization.

Carepy offers various benefits for caregivers (for example, health care workers,family members of the sick, especially the elderly) who have at their disposal a
simple but extremely effective tool to monitor the therapeutic adherence, theevolution of therapy and for establish a direct channel with the pharmacy and
Theresa Mulloy, Ewa Jankowska doctor or with the healthcare facility.
www.pugliasviluppo.eu
fdi@pugliasviluppo.eu+39 080.5498811

CAREPYDavide Sirago
davide.sirago@carepy.com

Carepy is already active in Italy in about 300 pharmacies and 250 medical doctors
where it has already generated:• an increase in patient compliance averaging 25%• a 20% increase in revenues from products promoted through the platform• and an increase in pharmacy returns of 25%
We are currently in negotiation with two Italian healthcare companies to include
Carepy in several hospitals for the management of chronic diseases.
Thanks to its extremely innovative approach combined with the potential wideranging impact on public health, Carepy was awarded the 2016 “Innovation Award
Prize” by the Italian President of the Italian Republic, Sergio Mattarella.

BUSINESS OPPORTUNITY

The company is looking for financial partners to finance the development of newchronicity and deospedalization management platforms to integrate with thecurrent software solution.
The company is looking for industrial partners to develop projects ininternationalization in Germany and the United Kingdom.
6

CALABRIA | Breathless:screening test of lung injury
Proposer: Biotecnomed scarl
Sector: e-Health

Focus:PROJECT DESCRIPTION

Between 5th and 9th December 1952 in London more than 4000 people alreadysuffering from lung diseases, died due to a thick blanket of smog that stagnatedin the city. The most common environmental pollutants are represented by fine
powders (from industrial emissions, vehicle exhausts, asphalt and vehicle wear),carbon monoxide (from the combustion processes of vehicles and industrial
plants), from nitric oxide and sulfur (which are formed as a result of combustion
and are produced by vehicles, industries and domestic and office heating). These
substances penetrate the respiratory system and induce the development of lunginflammation resulting in coughing and breathing difficulties that may culminate,
if the subject does not move away from exposure, to the development of chronic
obstructive diseases such as bronchitis, chronic obstructive pulmonary disease(COPD), emphysema and lung cancer. Moreover, in people who already have alung disease, exposure to environmental pollutants, even those that are indoor(home heating or cigarette smoke) can worsen the pulmonary state, leading toan increase in hospitalization and the social and health costs associated with it.
For airways problems, prescription of antibiotics is often done empirically byphysicians.

BUSINESS OPPORTUNITY

The value proposition of Breathless lies in the advantages it offers compared toorganizational aspects. The distinctive benefits are therefore evident:
1. for patients: targeted and more effective therapies and in case of antibiotic
therapy reduction of the resistance connected to it
2. for physicians: reduction of the prescription of inappropriate drugs

CONTACT INFO

Biotecnomed scarlwww.biotecnomed.it
info@biotecnomed.it
T. + 39 0961/3694280
Prof. Giovanni Cuda,
Dott.ssa Simona Lombardi

3. for the health service: savings in terms of social costs (WHO HealthStatistics
and the Global Burden of Disease study document how in Europe each year
about 48 billion euros / year are spent on the treatment of asthma, chronic
obstructive pulmonary disease (COPD), lung cancer and pneumonia and thisfigure reaches about 300 billion euros a year if we consider the value of waiting
life lost correct for disability)
Patent for the screening test of lung injury in subjects exposed to environmental
toxicants is pending in Italy and an extension to PCT application has been filed.

7

CALABRIA | MATE - (Multifunction Assistantfor liTtle kids and the Elderly)
Proposer: Biotecnomed scarl
Sector: e-Health

Focus:PROJECT DESCRIPTIONMATE is a weareable device, in the form of a bracelet, and a software platform.
Using the potential of the Internet of Things, through a simple App, it will allow
the activation of a wide range of services to be addressed mainly to the vulnerable
sections of the population, with specific reference to the elderly people (> 65
years), to children and to people with cognitive and/or motor impairments.
The device will have a NB-IoT or LTE-M communication module, an Inertial
Measurement Unit, wireless charging and energy harvesting and an audio unit. It
will allow to:• record and collect real-time data from the wearing subject (heart rate)• geolocalize people• detect falls and send alarms• play notifications and reminders, in order to enhance compliance with therapies• perform simple cognitive rehabilitation tasks for people with mild cognitive
impairment
It will have a simplified two-keys interface and can be reprogrammed andpersonalized (alarms, tasks, reminders, ...) through an app for caregivers, using a
dedicated web platform.

BUSINESS OPPORTUNITYCONTACT INFO

Biotecnomed scarlwww.biotecnomed.it
info@biotecnomed.it
T. + 39 0961/3694280
Prof. Giovanni Cuda
Dott.ssa Simona Lombardi

8

By 2030, a quarter of the EU population will be over 65. The annual expense
for services and caregiving to weaker sections is constantly increasing. MATE isaddressed to weak people (elderly or kids) and to their family caregivers whoneed to enhance their relatives’ autonomy, without the need of a professional
caregiver.
The improvement of compliance with therapies will dramatically reduce
rehospitalization rate (about 50% of cases are due to bad adherence to therapies)
and cognitive rehabilitation tasks, executed within personalized exercise programs,
will thoroughly improve autonomy in elderly people, with benefits on family
welfare and National Health Services.
The first prototypes of MATE will be tested by the end of 2019. We are looking fora partner for the industrialization of the product.

CALABRIA | SleepAnalyzer

Proposer: Biotecnomed scarl
Sector: eHealth

Focus:PROJECT DESCRIPTION

SleepAnalyzer consists of a tiny device and a method for detecting obstructive
sleeping apnea (OSA) (and other sleep disorders) through a continuous nightrecording of RR intervals (inter-beat intervals). The proposed device is based ona photoplethysmographic sensor (PPG) that can be easily worn on the ear, or
pinned to an earlobe. No other equipment is required (such as oro-nasal probes,
chest straps, etc...), that may be annoying for people who need to check their
sleep quality or the presence/absence of a sleep disease.
Efficacy of the solution in detecting sleep disorders has already been validated in
two clinical studies. Another multicentric study is presently ongoing.
In our trials, OSA and REM sleep behaviour disorders have been detected with a
100% accuracy.
The device and method have been patented in Europe (EP3267880, granted). We
currently have a prototype that is being experimented.

BUSINESS OPPORTUNITY

SleepAnalyzer can be easily used by people for monitoring their sleep quality. It
is very suitable for large scale screening of sleep diseases, such as obstructive
sleep apnea. EU countries, at the moment, require a health check before issuingor renewing driving licenses. In particular, people suffering from apnea cannot
get their driving license before undergoing proper treatments. Apnea screening
is currently done using a questionnaire, which is very prone to false negatives (orcounterfeiting). SleepAnalyzer can provide an easy, low-cost and effective solution
to competent authorithies for the improvement of road safety. It can also be used
for assessing the efficacy of therapies.

CONTACT INFO

Biotecnomed scarlwww.biotecnomed.it
info@biotecnomed.it
T. + 39 0961/3694280
Prof. Giovanni Cuda
Dott.ssa Simona Lombardi

We are looking for an industrial partner for either:• selling/licensig our intellectual property, or• developing and commercializing the new product.

9

CALABRIA | TremorAnalyzer

Proposer: Biotecnomed scarl
Sector: e-Health

Focus:PROJECT DESCRIPTION

TremorAnalyzer is a portable wearable device and app for the correct
identification of Parkinson’s disease, thus avoiding misdiagnoses in case of benign
tremor, like essential tremor.
The system consists of the following parts:• two or more electromyography (EMG) small sensors attached to the arm• a master module, wearable in the form of a bracelet/watch, which acquires andsynchronizes the signals coming from the EMG sensors• an (optional) accelerometric module• a portable device (smartphone or tablet) interfaced with the master module
via wireless protocol (e.g. Bluetooth Low Energy) for signal visualization,
analysis and presentation of results, archiving and database management of theanalyzed subjects.

BUSINESS OPPORTUNITY

Tremor Analyzer can be used by specialists (neurologists) for early screening ofParkinson’s disease with subjects showing tremor motor symptoms, thus avoiding
several annoying and expensive clinical and instrumental examinations (e.g.:
scintigraphy), with benefits on National Health Services.
It could be easily used also by medical practitioners and family doctors forlarge scale screening purposes, without the need of complex and expensive
equipment. The use of an app and distributed database could be useful forcollecting epidemiological data and keep track of disease progression or efficacyof therapies.

CONTACT INFO

Biotecnomed scarlwww.biotecnomed.it
info@biotecnomed.it
T. + 39 0961/3694280
Prof. Giovanni Cuda
Dott.ssa Simona Lombardi

10

We have a patent pending for this device in Italy and have a prototype developedthat is currently being experimented.
We are looking for funding or an industrial partner for the development of the
product/service.

LAZIO | ABILITA: a mobile application to
support disabled, elderly and complex(health)care populations
Proposer: I-PRO
Sector: IT FOR HEALTHCARE

Focus:PROJECT DESCRIPTIONWith the ABILITA project we developed a web application dedicated to persons(children and adolescents) suffering from rare diseases and disabilities.
Starting from the realization of a complete database of medical records andhealthcare information managed by the reference center/center of excellence,patient’s key data are made accessible to a network of family members,
caregivers, medical and paramedical staff who can then cooperate in the effort tosustain the patient in his dailies as well as healthcare related activities.
The Project acronym refers to the patient who, at the centre of the process,enables, abilitates, the others in the network to get access to his own sensible data
via his mobile phone, with full guarantee of privacy protection.
ABILITA received then a second round of Regional public funding (total >500.000 eu), for a wider project aiming to support the integration of the networks
sustaining disabled, elderly and high complexity care populations.
Three different networks have been identified around the patient: the first two
institutional and formalized to varying degrees, the National Health System
Network (NSN), and the Social Services Network (SSN); the third informal andmostly voluntary, the Territorial and relational Proximity Network (TPN), madeup of family members, friends and those of simple proximity including voluntary
associations, social cooperatives, non-profit organizations. The TPN is a real
network, which exists and operates before any attempt to formalize it, but
its formalization allows integration with institutional networks and offers theopportunity to enhance the social capital.

CONTACT INFO

InformaPRO s.r.l. (I-PRO)www.informapro.it
amministrazione@informa.pro
T. +39 06 5502218
Francesca Incardona
Dario Corsini, Francesca
Ferrucci

The wider ABILITA aims to achieve social benefits, by limiting theinstitutionalization of patients, economic benefits, by reducing healthcare costs,
entrepreneurial profits, by stimulating the production of new services and thegrowth and creation of new professional figures.
The business model of the project envisages income from: patients associations,
pharmaceutical, medical and para-medical device companies, insurancecompanies, public and private health institutions.
Natural co-funder of ABILITA are telecom, IT, insurance companies.

BUSINESS OPPORTUNITYABILITA is a light but powerful application, in accordance with ethics and privacy
requirements by design: the patient, at the centre, share his/her data with thepersons he/she chooses.
ABILITA answers to the unmet need of integrated support for those populations
who suffer for a long term or chronic impairment but who are (or could be, thanks
to the application) still living in their homes. The target population is very large
and growing at European level (e.g. the elderly).
The business model foresees a for free distribution of the application to thetargets, with income from: extra services, highly focused advertisement, analysis
of aggregated data.
The market is made of patients associations, pharmaceutical companies, medical
and para-medical devices companies, insurance companies, public and private
health institutions.
The business opportunity is offered to IT, Telecom, insurance companies willing to
co-fund the development in Italy and the joint marketing of the application.
11

LAZIO | Aenduo Biometrical IOT

Proposer: AENDUO SRL
Sector: DIGITAL HEALTH

Focus:PROJECT DESCRIPTION
Aenduo makes it easy to share health biometrics generated in any context.
We have an innovative digital health solution that tracks the full spectrum of
health data including biometrics, activity, nutrition, sleep and weight.
Our solution collects, connects and standardizes data from hundreds of medical
devices and apps (glucometers, blood pressure monitors, oximeters, ECG, etc.)
leveraging the complexity of managing a huge variety of different technologies.
Software Vendors, System Integrators and Medical Device Manufacturers havebeen successfully using our solution from over 3 years to make health metrics
connected for thousands of patients.
Companies such as Linde Group, MSD, Engineering, Dedalus, Octotelematics havealready selected Aenduo for their connected-healthcare solutions.
Aenduo has been awarded with several prices and grants.

BUSINESS OPPORTUNITY
The global mhealth technology market has a 37.7% CAGR.
Aenduo is already recognized in Italy as a top provider of biometrics data; we arecommitted to keep this position increasing rapidly the adoption of our services bysoftware vendors, system Integrators and medical device manufacturers.
We propose an extremely advantageous partnership offering:• the use of the solution at very competitive conditions to make your own
products and solutions “biometrical connected”

CONTACT INFO
Aenduo srl

www.aenduo.com
marcello.pediconi@aenduo.com
T. +39 3351556753
Marcello Pediconi

12• a co-investment package with the participation of an investment fund alreadyinterested to invest.

LAZIO | ASSIOMA PROJECT

Proposer: TOPNETWORK SPA
Sector: E-HEALTH / M-HEALTH

Focus:PROJECT DESCRIPTION

The objective of Assioma project is to realize a software platform able to provide
new services supporting medical care for hospitalized children. The platform willinterconnect the involved main stakeholders (children, medical staff, parents),
bringing better quality of care and more appropriateness to diagnostic andtherapeutic activities. Using gamification technologies, artificial intelligence, cloudcomputing and mobile applications, the project aims at achieving the following
goals:• facilitate the children symptoms analysis• facilitate the therapy application to the children (both in hospital and home)• improve the communication between children, parents and medical staff in theentire process of care
• decrease the anxiety related to medical procedures (such as blood tests, x-rays,etc.)• facilitate the follow-up of the hospitalization to the patients home
• provide telemedicine services• allow doctors to share data and information on patients during stays in different
hospitals• reduce waiting times in the day hospital• provide support to the parents (e.g. therapy plans during hospitalization,
recommendations and prescriptions to be followed, control over therapies,
results of exams, hospital services, etc.)

CONTACT INFO
Topnetwork SpA

alberto.ferraiuolo@top-network.it
T. +39 0632095400
Alberto Ferraiuolo

To ensure the future competitiveness of Assioma project, the development
strategy will rely on the delivery of new mobile applications able to support
children with specific diseases (e.g. learning difficulties, communication
impairment, autism, dyslexia, attention deficit hyperactivity disorder, diabetes,etc.), leveraging new technologies on gamification, artificial intelligence, machinelearning, 5G, 3D printing, user experience, virtual reality, cyber security and latest
medical research and experimentation.

BUSINESS OPPORTUNITY

The business opportunities of such Assioma technology are vast, since the
combination tablet/software is very versatile and applicable to several cohortof patients and diseases. In the current medical scenario, dominated by the
e-Health, the added value of Assioma for the different set of stakeholders is below
summarized:• children: improvement of care and better response to therapy• hospitals/medical organizations: optimization of the medical activity• parents: better organization and sense of control over their children’s disease
We are looking for partners which are interested to invest in the further
development of our system. The researched partners might be both financial
ones (e.g. venture capitalists, business angels, banks, etc.) interested to financethe project development, and industrial ones (e.g. hospital IT providers, medical
equipment providers, etc.) interested to integrate their products with the Assioma
new services.

13

LAZIO | MRT-DSS (MOLECULAR RADIO
THERAPY-DECISION SUPPORT SYSTEM)
Proposer: KAY SYSTEMS ITALIA SRL
Sector: DIGITAL MEDICINE FOR CANCER THERAPY

Focus:PROJECT DESCRIPTIONCONTACT INFO

The project deals with the realization of a digital patient and avatar topersonalized MR Treatment, a decision support system (DSS) for optimisingand increasing MRT effectiveness. A further innovative concept consists on the
integration of the DSS with advanced wearable gamma cameras that strongly
increase precision of treatment with a total comfort for patients. The results of theindividual biokinetics study will be collected, and an integrative patient-specificdigital representation achieved using radiological, functional and other nuclear
medicine images, after improving the quality of the latter that is notoriously
low. Population-specific data will be also used for treatment planning creatinga patient avatar that consists of a multimodal representation as time changes(biokinetic, for all organs and tissues).

Kay Systems Italia Srl
www.ksi.it
aec@ksi.it
T. +39.06.5427991
Matteo VivianoRadiometabolic therapy consists in the administration of radioactive isotopes(radiopharma-ceuticals) and is widely used in the oncological field. Administrationof radiopharmaceuticals labeled to the target tumor allows an effective andprecision medicine that preserves healthy tissue while minimizing side effects
and destroying cancer. This allows numerous advantages in terms of lengtheningof the average life and improvement of the quality of life of patients with cancer.
The attention of the medical world is increasingly focused on the developmentof new molecular radiopharmaceuticals for personalized medicine, which allow
to be alternative or even to replace the traditional chemotherapy, such as in themetastatic prostate cancer or breast cancer using the 223Radium or with the newgeneration alpha-emitters like the 227Thorium to treat Non-Hodgkin’s lymphomas.
Because of the introduction of new advanced radiopharmaceuticals, patients’life expectancy has increased and with it radiometabolic therapy centers are
expanding, in fact one million patients every year in Europe are treated with these
nuclear methods.

Moreover, the DSS will support: establishing therapeutic effectiveness, absorbed
dose-response and absorbed dose-toxicity correlations; combining several
radiation therapy modalities for improving geometry; performing follow-up
and future decisions for health care. These tasks will require a next-generation
hardware design to guarantee computational efficiency, and new dedicatedsoftware, for dynamic managing of integrated 3D visualization of multi-modal
images and dosimetry calculations.

BUSINESS OPPORTUNITY

The goal of the project is to create a decision support system based on Digitalpatient. The multimodal management of morpho-functional images and theTreatment planning will be done by creating an AVATAR of the patient through aninnovative SOFTWARE for Metabolic Radio Therapy/Radio Phamacy.
There are about 3.000 centers in EU and US that could be interested to buy anduse this innovative System for a total market value of about 1,2B Euro.

14

LAZIO | FILO BLU System

Proposer: GRUPPO FILIPPETTI SPA
Sector: LIFE SCIENCES – ICT FOR HEALTH AND WELL-BEING

Focus:PROJECT DESCRIPTION

Today citizens are more interested in actively collaborate to the management of
their health, pursuing the efficacy of the treatment also through the use of ICT
technologies.
In this context, the FILO BLU Project meets the citizens’ needs developing
a tool that allows to optimize the efficiency and the effectiveness of care
processes, as well as to increase the involvement of the patient and the caregiver(empowerment of the patient/caregivers).
The FILO BLU system, in particular, aims to improve the healthcare provision andtreatment of patients in cancer therapy and it consists of:• two APPs, one for the patient/caregiver and the other one for the medical team,aiming to support the doctor-patient communication and the home care
• a module for the interoperability with portable monitoring systems equippedwith a bluetooth interface, that is integrated to the patient’s APP• an expert system for the analysis of medical-patient communications that aims
to score the patient’s status (clinical and psychological) and that analyzes theflow of communications in order to signal to doctors, through an “attention”
score, potential critical situations (keeping into account both the written texts
and any physiological values monitored). That component will work using
algorithms in the field of sentiment analysis, machine learning and artificial
intelligence
FILO BLU has an interface similar to “whatsapp”, but goes beyond the typicalfunctions of systems like that. In fact, FILO BLU is equipped with features
specifically designed for the healthcare applications such as:

CONTACT INFO

• the dispensation of precompiled questionnaires to the patient/caregiver

Filippetti S.p.A.

• the scheduling, by the medical team, of automatic reminders for the patient

www.filippetti.it• the transfer of the monitoring parameters of the medical devices eventuallyworn by the patientgiovanni.libertini@
gruppofilippetti.it,
sergio.loriga@gruppofilippetti.it• the calculation of the “attention” score using Artificial Intelligence and Machine
Learning algorithms

T. +39 335.1394289• the integration with electronic medical records

Giovanni Libertini

BUSINESS OPPORTUNITY

Every day in Italy more than 1,000 new cases of cancer are diagnosed. In fact, it
is estimated that in our country there are about 373,300 new cancer diagnoses
during the year. The relationship between patient, caregiver and medical teamplays a key role in therapy.
FILO BLU can play a fundamental role in terms of improving the relationshipbetween the figures involved, thanks to the reduction of stress due to the direct
and indirect costs of the disease.
We’re interested in building partnerships and collaborations with Industrial
Partners offering already innovative solutions in the context of “Life sciences – ICT
for health and well-being”, in order to improve a more complete solution that will
be offer to the European market. It represents fertile ground because FILO BLU
respond to emerging communication needs in cancer supportive care.
We are also looking for financial partners interested in investing financially in thedevelopment and the commercialization of the FILO BLU System.
15

LAZIO | HA-R2EC

Proposer: MICROSIS SRLSector: E-HEALTH – ENGINEERING

Focus:PROJECT DESCRIPTION

HA-R2EC or his commercial name DIREC is a project that intend to setup an
innovative method in heart – desease field.
The aim of the HA-R2EC project, or its commercial name DIREC, is theimplementation of an innovative method of detecting cardiovascular emergencies
based on the use of a new non-invasive device, called DIREC, which will represent
a revolution in the field of clinical diagnostics and will enable faster management
and resolution of acute cardiovascular events. DIREC is a multi-purpose
instrument that allows you to integrate signals from diagnostic tools with blood
chemistry values, detected by a drop of blood, and the level of oxidative stress,
measured by a sample of saliva with a brand new biosensor device.
It will assist in the identification of fatal arrhythmias, acute myocardial infarction
and respiratory insufficiency induced by acute pulmonary edema.

CONTACT INFOMicrosis Srl
www.microsis.it
info@microsis.it,
r.antoniucci@microsis.it,
m.bevilacqua@microsis.it
T. +39 06 90400404
Roberto Antoniucci
Maurizio Bevilacqua

16

The project is carried out in effective collaboration between Microsis and CNRIC (Consiglio Nazionale delle Ricerche) and with the help of the Department of
Cardiovascular Sciences of “La Sapienza” to which a mandate will be entrusted ofresearch for the definition of interactions and evaluation criteria of the parameterscollected by the system. The use of DIREC will make it possible to get to thediagnosis quickly and easily and will lead to a reduction in healthcare costs due
to inappropriate hospitalization and clinical analysis. DIREC will be a portable
tool, easy to use and cheap, essential for the fight against sudden cardiac deathand myocardial infarction by fully responding to the area of ​​Life Sciences andAgrifood of the regional S3 (Smart Specialization Strategy). The system will also
be integrated with the historical SDRA database, containing the raw data ofthousands of electrocardiographic traces already collected by the University andby Microsis, to enhance an important diagnostic continuity also for the purposesof basic research.

BUSINESS OPPORTUNITY

We are looking for partners in medical-industrial field to industrialize the systemand start marketing in Italy and Europe.

LAZIO | Integrated health care pathway forpatients with severe acquired brain injury
Proposer: GELCO SPA - SENTECH SRL
Sector: HEALTHCARE/ICT SYSTEMS

Focus:PROJECT DESCRIPTION

The aim of the project is an innovative health care model, based on informationand communication technologies, which can support and facilitate the diagnosis,
the treatment, and the rehabilitation path in severe acquired brain injury (SABI)
subjects.
This is carried out through implementation of an e-Health system based on:
1. A system capable of integrating the results of different medical examinations andin particular coming from the analysis of EEG signals (auditory evoked potentials,
AEP), fMRI (connectivity maps), DWI (tractography), CT, and MRI images, inaddition to the clinical scale based assessment of the medical team (CRS-R).
2. A teleconsultation system that implements a powerful synchronization and comanagement on data and images with effective and complete voice / data /image connections. This allows a real time consultation among medical specialists
who practice in different geographical areas, resulting in a powerful clinicalsynthesis and achieving an effective diagnostic evaluation aimed at optimizing
admission processes in rehabilitation facilities. Moreover, teleconsultation is used
for monitoring of patient status, for a shared assessment by teams of specialists
located in distant sites, of the status of the rehabilitation course.
3. After hospital discharge, telecare gives remote assistance of the patient at homeor in local care facility, through training, monitoring and interaction of the healthfacility with the local caregivers.
Telecare includes an interactive system for cognitive and neuro-motor rehabilitation
installed at home and controlled through internet or sat links (type KA-SAT).

CONTACT INFOGELCO SpA – SENTECH SRL
www.gelcospa.it,
www.sentech.it
emancini@gelcospa.it,
sentech.roma@gmail.com
T. +39 3356254889,
T. +39 3351405358
Enzo Mancini
Michele Russo

The system follows the patients during all the phases, from the preliminary
diagnosis to the choice of the best treatment, and during the entire rehabilitation
course. Therefore, the system will improve the diagnosis and treatment accuracy,
resulting in lower expenses for the national health system and optimized assistanceto the patient and his family. The project includes the creation of a database thatkeeps all the useful medical information, such as the medical examination results, ina secure server easily reachable by all the trained and certified personnel.
This system allows a channel of direct access to high specialization realizing in realtime the HUB-SPOKE operation strongly desired at national and regional level. The
HUB-SPOKE link helps to improve and standardize the patient care path thanks
to the multidisciplinary comparison carried out in augmented virtual reality. The
system is also an excellent consulting tool for HUB-SPOKE planning of complex
operations such as neuro or cardiac surgery.

BUSINESS OPPORTUNITY

The purpose of our participation is to consider business opportunities that follow a
logic of attracting investments in Italy, i.e., we are looking for foreign companies thatinvest or co-invest in the project.
More specifically, we actively seek for Radiology Information System database
companies who want to integrate our system to expand the functionality of
their products, moving from “second opinion” teleconsultation systems to realtime interactive teleconsultation systems suitable also for surgical pre-planning.
Furthermore, we look for companies that produce neurorehabilitation systems to be
integrated with our teleconsultation and telecare system to provide a reliable andaffordable tele-rehabilitation system at home.

17

LAZIO | LIFESEEDER and LIFELAB

Proposer: LIFESEEDER SPA
Sector: LIFE SCIENCE

Focus:PROJECT DESCRIPTIONLifeSeeder is the first equity crowdfunding platform exclusively focused on Life
Sciences authorized by CONSOB. LifeSeeder aims at facilitating the matching
between Life Science enterprises with highly innovative projects and specialized
investors or big companies. This is in order to realize the mission of being a real
meeting point between companies looking for new capital and investors in the
sector.
LifeSeeder was founded by the Health Cluster of Lazio C.H.I.CO. and leading
stakeholders in the Life Sciences sector. It represents the last step in a processthat aims at developing innovation by connecting the world of public and private
research to companies and private finance. LifeSeeder is based in Rome, with
headquarter in Tecnopolo, the technological hub of the city of Rome, conceived asa scientific research pole of excellence. It also operates in Berlin and Tel Aviv.
LifeLab is a new project that would like to create a hub of Life Sciences ofinternational relevance specialized in the fields of Pharmaceutical, Biomedical andBiotechnology. It wants to connect scientific and public institutions and the worldof enterprises and startups, stimulating economic development throughout the
supply chain from basic research to production.
The main goal is to create a meeting point for research centers able to attract
investments.
The added value of LifeSeeder is its evaluation process based on three steps:
a scientific evalutation entrusted by the Scientific Committee of Cluster C.H.I.CO.
for a scientific assessment. The Committee is composed by distinguishedacademics and top level researchers.

CONTACT INFO
Cluster CHICO

www.lifeseeder.com
info@lifeseeder.com
T. + 39 340.5450662
Sara Pisano

A legal and fiscal evaluation committed to DLA Piper and a Market Committee
availing of specialists, such as SIB, Sapienza Innovazione and ATID.
During pre-matching, projects are shown to professional investors, big corporates,
funds that can make their own investment appraisals before the online launch on
the platform.
In particular, today our platform is looking for start-ups, innovative SMEs, highly
innovative Life Sciences projects and investors who might become part of our
network and therefore take advantage of our services to carry out our project
together with us.

BUSINESS OPPORTUNITY

Lifeseeder has an important portfolio of innovative projects: over 60 viewed
and 14 admitted to evaluation process. The business sectors of this projects are:medical device, diagnostics, telemedicine, pharmaceutical, Iot, agri-food andnutraceutical. Lifeseeder selects and presents the new projects to innovative
investors, as a business matching facilitator for startups, SME’s and investors.
LifeLab wants to be a territorial network for the transfer of technologicalinnovation, as well as supporting and strengthening start-ups, helping SMEs togrow, also providing guidance and commercial and financial tutoring.

18

LAZIO | Platform for early and non-invasive
diagnostics of neurodegenerative diseases
1.3
Proposer: ACT OPERATIONS RESEARCH IT SRL
Sector: LIFE SCIENCE

Focus:PROJECT DESCRIPTION

The project aims to improve the diagnostic accuracy of neurodegenerative
diseases by integrating Artificial Intelligence and with Innovative Biomarkers.
Low sensitivity and specificity of current diagnostic methodologies lead tofrequent dementia misdiagnosis; this raises the need of more efficient integrationof biomarkers with multidimensional clinical data. Our goal, through aninterdisciplinary approach, is to implement a new diagnostic mathematical modelby mining large databases of clinical variables of Mild Cognitive Impairment,
Alzheimer’s disease and other demented patients and controls subjects forproviding probabilistic early diagnoses. The activities include the developmentof a detailed Ontology for multidimensional clinical datasets, the implementationof Artificial Intelligence methods to extract knowledge, the measurement ofinnovative biomarkers in clinical biological samples.
The diagnostic models will allow focusing on essential clinical variables andsupport clinicians in the early diagnostic process.
The project, of value around 1 million euros, is developed by ACT Operations
Research, a math-technology company, European Brain Research Institutefounded by the Nobel Prize winner Rita Levi-Montalcini, and the Italian National
Research Council.
We are interested in finding research, industrial and financial partners to set up a
Bio-Informatics & Modelling (BI&M) competence center, to support the healthcare
sector with Artificial Intelligence and Advanced Modelling techniques.

BUSINESS OPPORTUNITYCONTACT INFOACT OPERATIONS RESEARCHIT SRLTo evaluate the business opportunity proposed with the project has to beconsidered: the background, the market position, and the scaling plan of ACT
Operations Research (ACT OR).
BACKGROUND

www.act-operationsresearch.com ACT OR is a math-technology company. ACT OR, based on a proprietary decision
science platform, supports crucial business decisions and process control
raffaele.maccioni@act-operationsresearch.com
accounting@act-operationsresearch.com by advanced analytics as math-optimization, artificial intelligence, dynamic
simulators, and predictive models. Such software technologies, combined with
T. + 39 335.499619“big data” supports complex decisions and systems control.
Raffaele Maccioni,
The ACT OR decision-science platform enables sophisticated “what-if” analysis
Giuseppe Confessore
as well as the real-time optimization (example are supply chain optimization,
dynamic price optimization, simulators etc.). The application of such technology
and expertise in the fields of robotics and science of life is a strategic line ofdevelopment for ACT OR. After intensive work, developing know-how, references,and technology, ACT OR is now acting to grow internationally.
Highly contribute to the co-development of innovative solutions for the diagnosis
and care the joint-ventures with excellence centers like the European Brain
Research Institute (EBRI) “Rita Levi-Montalcini Institute (Roma, Italy) and the
Italian National Research Council (IASI-CNR; Roma, Italy), with the know-how of
Innovative Biomarkers in the Neurodegenerative diseases and data mining andnew algorithms.

19

LAZIO | Platform for early and non-invasive
diagnostics of neurodegenerative diseases
2.3
Focus:

BUSINESS MODEL
The acronym of the project is MoDiag, which stands for Modelling for Diagnostics.
The idea behind such a research project is the development of services and technology
in the science of life and healthcare areas.
The ideas come from the awareness that advanced modelling techniques could
dramatically and positively impact the prevention, early diagnostics, and care ofdiseases. In addition, the decision science improves the operations, the service level, andreduce costs of hospitals, clinics, and laboratories.
Is not easy for a hospital, a medical organization, a bio-science laboratory, where theprevalent culture comes from other disciplines, to adopt such techniques and technologies.
The ACT OR projects aims to offer services in the mentioned fields, by a Bio-Informatics& Modelling (BI&M) competence center, levering the existing ACT OR expertise andtechnologies combined with medical and bio-science competences of European Brain
Research Institute (EBRI) “Rita Levi-Montalcini Institute (Roma, Italy) and the Italian
National Research Council (IASI-CNR; Roma, Italy).
At the base of the mentioned technology, there is a multi-analytical decision science
platform (called Bloomy Decision), permitting the fast-built & deploy of web-based
analytical applications. Parallel & distributed computing, the capability to manage a big
amount of data efficiently are a crucial characteristic of such a platform.
The solution, by the decision science platform, enable the application of artificial
intelligence for the early diagnosis of diseases. The platform is specialized for the type of
disease starting from the most impacting such as the Alzheimer’s disease. The platform
can be used by a single center or clusters of centers under a cooperation agreement.
The platform can also be used for research activities. The MoDiag project is financing the
set-up of such a solution.
ECONOMICS (preliminary):In the world >50M people suffer from dementia, with a rough global cost exceeding 500
billion Euro.

CONTACT INFOIn Italy it is estimated that >1,000,000 people suffer from dementia, of which >600,000
are affected by Alzheimer’s Disease, and family members involved in caregiving are
estimated to be > 3,000,000. The average cost per patient is 9,000-16,000/year, with a
www.act-operationsresearch.com total cost > 12 billion Euro. This is potentially a very large market, including 478 Dementia
raffaele.maccioni@act-operationsresearch.com centres (34 in Roma Region) in public health services only, to which a large increasing
accounting@act-operationsresearch.com private market must be added.
ACT OPERATIONS RESEARCHIT SRL

T. + 39 335.499619
Raffaele Maccioni,
Giuseppe Confessore

The economic advantage for an early and accurate diagnosis would lead to a substantial
cost saving, particularly for home caregivers and hospitalisation. Furthermore this would
allow to start as soon as possible a proper drug therapy, that would slow down or delay
the disease onset. Delaying the AD onset would lead to a net decrease of patients
number, with a consequent cost saving for health system. US Alzheimer’s Association
estimates that, if in 2025 a new drug able to delay AD onset by 5 years would come tomarket, people affected by AD would decrease by 40% by 2050, with a related direct
and indirect costs saving up to 36% (Biopharmaceutical Research Companies, 2013
Report; Alzheimer’s Association: Changing the trajectory of AD disease, 2015).
A similar model in the UK, where almost 1 million people are affected by dementia,
shows that if a new disease modifying drug would be made available on themarket in 2020, this would lead to a decrease in patients and cost of about 20%,with a disease onset delayed of 2 years and about 35% if the drug is able to delayby 5 years the onset. The cost saving would be equally distributed between direct
costs and indirect costs (from Alzheimer’s Research UK, Defeat Dementia, 2015).

20

LAZIO | Platform for early and non-invasive
diagnostics of neurodegenerative diseases
3.3
Focus:

Concerning misdiagnosis, a US study estimates that the excess medical cost for
Parkison’s Disease misdiagnosis, often with symptoms overlapping other forms ofdementia, may exceed 10000 Euro/year of incorrect diagnosis. This underlines that not
only an early, but also reliable and diagnosis, are crucial for saving healthcare costs.
Delaying the disease onset not only would substantially decrease the economic burden
for public health systems and families, but would also immensely benefit patients andtheir relatives from the social and psychological point of view, with a positive impact on
the quality of everyday life.
With the MoDiag project we aim to offer client-server based services to public andprivate neurology and geriatric departments, on a cost/year basis, which will provide
in-silico diagnostics and diagnostic work-flow optimization. Moreover, as the patient
database will increase in size thanks to new data entry by the health personnel, thesystem will also select new biomarkers and clinical endpoints with increasing statisticalreliability.
Our Healthcare Operations Planning aims to develop, considering the ROI such solution,
an application to predict, simulate and plan resources for early and most accurate
diagnosis with a cost from 5K€ to 80K€/ year. Set-up services to be added for about
20-80 K€ per application.
A solution for the optimization of the drugs inventory can cost from 2 to 20 K€ per year
per warehouse and a set-up fee around 10-80 K€.
Diagnostics Intelligence: 30-80 €/patience per year per type of disease.
New investments may be crucial for:server system management,
development of more efficient modelling and data mining approaches
client side customization to deal with the high heterogeneity of the Italian HealthsystemMarketing of services

CONTACT INFOACT OPERATIONS RESEARCHIT SRLNew Biomarkers validation in clinical trials
Financial evaluation and modelling of cost saving impact on Health institutions
ADDITIONAL INFO ON ACT OR

www.act-operationsresearch.com Characterized by continuous research, ACT OR is also a shareholder of a spinoff ofraffaele.maccioni@act-operationsresearch.com Sapienza University in Rome, Italy, focused on Operations Research themes. The ACT
accounting@act-operationsresearch.com OR team is composed of 40 specialists which include several PhDs.
T. + 39 335.499619
Raffaele Maccioni,
Giuseppe Confessore

ACT OR has over 20 years of experience in operations research, predictive analytics,
artificial intelligence, simulators, and advanced control logic.
After intensive work, developing know-how, references, and technology, ACT OR is now
acting to grow internationally.
The ACT OR’s activities include the participation to several Research & Development
projects financed by European funds.
As a testimony of the ACT OR expertise, we noted that, by a project for the customer
Europcar (HQ Paris - FR) have been selected as finalists by the Institute for Operations
Research and Management Science (INFORMS) for Franz Edelman Award, the world’s
most prestigious international award for achievement in the practice of Operations
Research.
ACT OR, presenting the characteristics of a start-up, from the innovation perspective,
is a low-risk and high potential opportunity for investors willing to lever the emerging
market of the Advanced analytics, Artificial intelligence
ACTOR has offices in Italy with Rome and Milan and is now working on aninternational expansion. We’ve established ACTOR UK (London) and ACTOR US(Charlotte, NC).
21

LAZIO | TraiNurse – From an Industrial
Research Project to Commercial
Development
Proposer: ARTMEDIAMIX S.R.L.
Sector: E-HEALTH

Focus:PROJECT DESCRIPTION

The increase in aging population, chronic diseases and disabilities, has put thehealth professionals in a challenging position, where the update of competences
and skills is continuously required.
Moreover, the national healthcare systems are transforming their assets to takeadvantage of the digitalization and respond to the new needs of the citizens,
including the increased demand for medical home care assistance.
However, nursing performances can be affected by factors such as age, education,
expertise, etc., with an impact on knowledge transfer and on the sharing of skills
and experience between different generations and levels of professionalism.
Artmediamix seized the opportunity within the need of uniformity, consistency
and valorisation of the nursing profession and initiated TraiNurse, a project for thedevelopment of a web mobile digital platform, where multimedia content will bedelivered to the nursing professionals in a unique, standard-codified language andthrough an integrated App.
The industrial research project TraiNurse will develop the prototype of the “first
App for the valorisation of digital skills of nursing professionals” by the targeted
delivery of multimedia and interactive content with a high degree of cognitive
impact.
All the content will be based on ICNP language, i.e. the “International Classificationof Nursing Practice”, thus recognized by the International Council of Nurses (ICN).
As such, the prototype will include a number of selected clusters of clinical areas,
i.e. it will not codify the whole ICNP.

CONTACT INFO

BUSINESS OPPORTUNITY

Artmediamix srl

The research will look at new communication codes with major interest, in order toallow the connection of a large number of users worldwide.

www.artmediamix.com

The aims of this project include:

info@artmediamix.com• the dissemination of re-usable scientific contents that will be:

T. +39 06 95223008

produced
and guaranteed by the Scientific Committee

Gian Marco Sandri – CEO
Artmediamix srl, Andrea
Ortenzi – Direttore Marketing& Brand Progetto TraiNurse,
Caterina Zavolta – ProjectManager Progetto TraiNursetested
within the accredited health care institutions
compliantwith the International Classification of Diseases (ICD)• the spread of ICNP language and the dissemination of best practice for ameasurable value of nursing professional performances and results• the promotion of the development of digital skills and the creation of a national
and international community of nurses
The transition from the prototype to a commercial product and its commercial
development requires a further investment of € 4.000.000/€ 6.000.000.
EXPECTED RESULTS• Digital literacy• Standardisation and measurability of results• Increased accuracy of nursing diagnoses• Increased uniformity of the language at international level as a result of spread
and adoption of ICNP
• Empowerment of nursing profession

22

SARDINIA | Total Patient Management(TPM)
Proposer: INPECO
Sector: E-HEALTH

Focus:PROJECT DESCRIPTION

Building upon its in-depth knowledge of clinical processes and healthcare
dynamics, Inpeco is developing the digital complement for its solutions historically
based on total automation, complete traceability and open integration.
Total Patient Management (TPM) is a patient-centric and vendor-neutral digital
healthcare platform powered by automation and enforced by the Patient’s
biometrics.
The first product of this platform will be a cloud hosted Patient health record
which is seamlessly fed with reliable clinical data from automated and traceable
processes; the future portfolio offering has the ambition of becoming the supply
chain for personalized medicine of the future.
Inpeco is building in Sardinia a demonstrator to prove the power of its vision andfine tune the technology and business processes required for global scalability
and success.
The working relationship with CRS4 (a public research centre owned by the
Region) and the Health IT Infrastructure currently present, were key drivers forchoosing Sardinia as the first deployment site.
Inpeco has had an innovation centre hosted within the Scientific and TechnologicalPark of Sardinia since 2010 and has steadily increased investments on site.

BUSINESS OPPORTUNITY

The TPM project was born with global ambitions and will require consistentfinancial backing for its worldwide scale-up and deployment.

CONTACT INFO
InpecoThe demonstrator is only the first step in realizing a digital healthcare platformthat will benefit Patients and all healthcare stakeholders.
Multiple business opportunities can be exploited by both building clinicalapplications on top of the platform or deploying it globally.

www.inpeco.com
davide.pedrazzini@inpeco.com
T. +41 (0) 91 911 82 00
T. +39 340 3025570
Davide Pedrazzini

23

TUSCANY | BRAINCONTROL

Proposer: TLS FOUNDATION
Sector: DIGITAL HEALTH

Focus:PROJECT DESCRIPTION

BrainControl is a platform based on Artificial Intelligence for human-machineinteraction through bio-feedback. Its first application was addressed as BCI-based
augmentative and alternative communication (AAC), a sort “mental joystick”,
allowing people to overcome severe physical and communicative disabilities.
BrainControl BCI AAC fills a technological void for patients who are cognitively
aware, but completely unable to move or communicate, a state called “locked-in”,
and meets many of the unmet needs for patients in less advanced states who are
currently using or cannot use eye-tracking systems.
The main focus of BrainControl is the condition of those patients who suffer fromsevere disabilities caused by degenerative neuromuscular diseases (amyotrophic
lateral sclerosis, multiple sclerosis, Duchenne, etc.) or ischemic or traumatic
injuries. This target can be further segmented into patients in complete locked-instate (CLIS), for whom there is no other technology available on the market, andpatients in locked-in state (LIS), who can use, in some cases, other technologies,
but who also have unmet needs due to usability limits of most of the available
products.

BUSINESS OPPORTUNITY

Liquidweb recently achieved a first round financing of more than € 2 M and isactively looking for a second round to expand its market with the Braincontrol
Technology.

CONTACT INFOTLS Foundation Business
Development
Dr. Francesco Maria Senatore
f.senatore@toscanalifesciences.org
Liquidweb Srl
www.braincontrol.com
Pasquale Fedelep.fedele@liquidweb.it
T. + 39 0577/1916187
T. +39 328/7521583
Chiara Fedele
chiara.fedele@liquidweb.it
T. + 39 389/4259199

24

APULIA | NEXTOME – Indoor Navigation,
Indoor Positioning and Indoor
Tracking system
Proposer: NEXTOMESector: ICT

Focus:PROJECT DESCRIPTION

Nextome is a software technology company born with global ambition thattackles the challenges of indoor navigation. Since our first steps, we have travelledaround the world to benchmark our technology, meet potential customers andparticipate in international competitions. The start-up, founded by passionate
computer science students, is based in Apulia, Italy. After years of research anddevelopment on the indoor positioning and navigation system, the company won
multiple awards and international innovation challenges.
The patented technology utilizes smartphone sensors and low-signal Bluetoothbeacons leveraged by a physical model as well as A.I. algorithms to achieve
remarkable results. In a highly competitive market the solution stands out due
to its high accuracy (1-2 meter), great value and simple installation approach (nofingerprinting) that makes the system ready to use almost right away. Besides
the indoor positioning and navigation system, Nextome provides tools to manage
the infrastructure and analyse data in real-time. The patented Nextome indoor
location and navigation system is designed to be integrated into an existing
mobile application effortlessly. Furthermore, we also offer to customize your new
app containing the Nextome Technology plus individual, valuable features.

CONTACT INFOPUGLIA SVILUPPO
www.pugliasviluppo.eu,
fdi@pugliasviluppo.eu
T. +39 080.5498811

Nextome is a B2B software solution company providing corporates owners andmanagers of large buildings (including office buildings, hospitals, stations, airports,
factories, shops and malls, trade shows etc.) the opportunity to implement
mobile location based services to provide users (visitors, shoppers, employees,
contractors, etc.) with positioning and navigation / positioning and tracking
enabled apps to easily find point of interest, follow a guided tour, or facilitate
man machine interaction. Data collection and data analysis services are provided
for corporate customers, users can benefit from interactive services based on
applications location awareness provided Nextome.

BUSINESS OPPORTUNITY

Venture capital financing: We evaluate investment proposals including 500K(€) 1.5M(€) - these investments will be destined for expansion in the American market.

Theresa Mulloy, Ewa Jankowska Business partners: the possibility of making business agreements with local system
integrators for the construction of a solution suitable for several industries (eghealthcare and industry 4.0).
NEXTOMEwww.nextome.net
d.colucci@nextome.net
T. +39 0808806915
Domenico Colucci (Co-Founderand Marketing Leader)28

CALABRIA | Rail Transport System with
Convoys Automatic Composition
Proposer: Co.El.Da. Software SRL
Sector: RAILWAY TRANSPORT

Focus:PROJECT DESCRIPTION

The objective of the proposed solution is to improve flexibility, efficiency and to
reduce fixed management costs of Single Wagon Load (SWL) traffic, by adopting
a novel approach for wagons’ dispatching, formation of trains and the optimised
usage of railway paths. The solution is based on the integration of existing
technologies into a train-network management system that can be applied to
optimise the whole SWL delivery as well as specific SWL stages (such as train
formation operations). Other applications may be found for the automation ofcontainer movement in intermodal nodes (such as, dock to train) and other similar
scenarios. The approach will also create new market opportunities, for smalltransport operators and private clients, for new marshaling managers as well
as for “smart wagons” manufacturers.The solution aims to enhance the overall
competitiveness of the SWL traffic by achieving the following results:
1. Reducing the management costs (staff, depreciation, maintenance, energy) of
local SWL systems (maneuvering on track connection, shunting work centres,etc.) through automatic train formation and shunting of the wagons without
direct human intervention
2. Increasing the overall flexibility and reliability of the SWL traffic, allowing an
optimal use of the railways networks and raising their operational capacity,by adopting novel routing techniques for single wagons thanks to the fully
automatic management of train/wagon switch
3. Developing new business models based on the increased overall efficiency ofthe system that allows operators to serve profitably a much wider dynamic of
local transport demand

Co.El.Da. Software SRL

All the experiments necessary to demonstrate the feasibility of the project(construction of the prototype and handling operations) were carried out at the
San Ferdinando station in the port area of Gioria Tauro.

www.rts-agw.it

BUSINESS OPPORTUNITYCONTACT INFO

info@coelda.it
T. +39 0965 920584

Our company is available to collaborations in all sectors (mechanical, electronic,
data transmission, IT, etc.).
Specific opportunities for digital companies concern:
1. development of methods and secure protocols of communications between thevarious components of the system (eg between station and wagons)
2. study of signaling system (ETCS Level 3), concerning the continuous control of
the integrity of trains.

29

LAZIO | PickMeUp
1.2
Proposer: ITALY-INTENT SRL
Sector: SUSTAINABLE SMART MOBILITY

Focus:PROJECT DESCRIPTION
The PickMeUp project is aimed at researching and developing for an innovative
platform to support sustainable mobility that effectively integrates local public
transport with the private one.
The partners involved in the project development are:• Intent - responsible for the development of the platform• App to You - responsible for the development of the App• the Research Center for Transport and Logistics (CTL) of the “Sapienza”
University of Rome - responsible for the routes planning algorithms
The idea is to integrate and optimize the public service (bus,train,etc.) with whatis available at a private level, overcoming the most deficient situations of suburban
areas and small municipalities, through an information system that combines thedemand with a “just in time” response available at a certain time and for a certain
road route to be done.
By the platform, users will be able to know the offer available in real time on roadroutes, with updated information in real time on the state of public transport,
where provided by the public service operators, and mixed routes, where it ispossible to optimize travel using both public lines and private vehicles.
In addition, the platform will have to manage an area dedicated to the availabilityof passages (for example “BlaBlaCar”) both on offer and demand, therefore
integrating choice options also on routes badly served by public service or notreached by the most innovative car sharing systems.
The specific goals that we are pursuing:

CONTACT INFO
Intent Srl
www.intentsrl.it(website of the project underdevelopment www.e-muoviti.it)
amministrazione@intentsrl.it
T. + 39 06-9575098
Michela De Santis• to create a series of algorithms for routes planning• to devise a platform that can work in iOS and Android with APP for
smartphones and tablets, as a prototype of mobility support, integrated withthe control room for traffic and data of public transport and the availability ofthe private one• to implement a device for geolocation and WiFi connection of all vehicles,
public or private.
• The economic objectives have been hypothesized on two distinct commercial
channels:• license sale to individual municipalities / local authorities, estimated price € 100/ each• advertising sale (banners,etc.) to local companies, estimated price € 500 / each30

LAZIO | PickMeUp
2.2
Focus:

According to the estimated data, the business generated will produce aninvestment yield of 50%
Description

1° year

2° year

3° yearOverall Business102.000 €520.000€+ 102.000€

520.000€+ 520.000€+ 102.000€

Investments

50.000 €300.000 €550.000 €The PickmeUp platform can be replicated in different geographical areas, we arelooking for Financial and Industrial partners to promote Pickmeup beyond the
Italian territory.

BUSINESS OPPORTUNITY
From our analysis, the business opportunity is evident.
With an initial investment of € 300,000, a ROI will be achieved in just 21 months
and a further 128% return of the investment in 36 months, considering the morethan € 200,000 already invested by Intent and its subsidiaries.
For this type of investment, we envisage company’s shares in a NEWCO to beestablished between Intent and the investor. The investment can be seen as aparticipative loan, even temporary, with an exit value valued on a preventive
budget base.

CONTACT INFO
Intent Srl
www.intentsrl.it(website of the project underdevelopment www.e-muoviti.it)
amministrazione@intentsrl.it
T. + 39 06-9575098
Michela De Santis

31

LAZIO | Certified Zero Emission
Last-mile Delivery
Proposer: Regione Lazio, ZEDL partnership
Sector: LAST MILE LOGISTIC

Focus:PROJECT DESCRIPTIONZEDL proposes a “real zero emission last mile logistic and distribution”. It is basedon an integrated platform, which directly links energy generation and final use forgoods distribution, by means of an optimized algorithm.
At the moment, ZEDL platform (software and hardware, plus devices) has beendeveloper at TRL8 level. Next steps to the industrial implementation are:
Software:• making the dashboard of ZEDL compatible with major commercial software for
distribution management• creating a commercial package of the ZEDL distribution platform(energy+distribution+fleet management)
Hardware:• final industrialization and production of the ZEDL OBU’s (on-board-unit), tomake it compatible with major commercial trucks on the market• industrialization and production of the ZEDL energy management hardware
platformThus, a new start-up company is proposed, with the aim of:• creating a commercial “zero emission distribution platform”, which includes
also the energy generation and management, distribution optimization, fleet
management, charging infrastructure, etc…
• promoting the use of second life traction battery inside the energy platform, inorder to extend the actual life cycle of the electric vehicle’s batteries

CONTACT INFO

Prof. Giuseppe Tomasso
T. +39 0776 2993730
www.tomasso.site
tomasso@unicas.it• creating a “CO2 certification mark (carbon footprint)”, associated to eachdelivery, to report and certify the actual value of used energy and carbon
footprint of each specific delivery, by using the “well to wheel” approach. This
mark will include also production and recycling• providing a certified delivery service, to be offered to cities, private companies,
express courier and, in general, logistic operators

BUSINESS OPPORTUNITY

The business opportunity comes from the huge market of daily delivers performed
within the “last mile”, which has to be integrated to the strict pollution restrictions
all local governments are promoting inside the city centers. Approaching thismarket with a real-zero-emission distribution or, at least, certified carbon footprintdelivery will drive logistic operator to the strict rules of 2030 full green last milelogistic, established by European
Commission. The business approach will be:• Phase 1: creating a new start-up company, which owns all technologies, knowhow and IP’s developed inside the ZEDL project• Phase 2: developing a commercial platform for ZEDL and starting devices
production• Phase 3: creating a zero-emission last mile delivery service, to be offered to all
logistic operators in Italy
Shares of start-up companies will be available for external investors.

32

AOSTA VALLEY | Q-CAST,Interactive real-time multi-streaming
solutions for one-to-million communication
Proposer: QUINTETTO S.R.L.
Sector: Creative Industry/Healthcare/Smart Mobility

Focus:PROJECT DESCRIPTION

Q-cast turns a smartphone into a real-time mobile broadcasting & streaming
service, allowing anyone to become an in-field reporter within their trade.
Quintetto has developed the world’s first multi-camera mobile streaming solution(Contemporary outgoing streaming of the smart-phone Front and Back camera).
Combining true real-time with intelligent usage of compressed data to enable
a multitude of services both for urban and rural areas. Q-cast is a cloud-based
solution that allows a smartphone to communicate via both audio and video
with the Q-cast control-room. The Q-cast control room can integrate seamlessly
with any existing service whether it is for call-centers, civil services, healthcare,traditional broadcasting companies, etc. The Q-cast solution adheres to thestrictest of security and privacy rules.
Q-cast In-field solution
Use the mobile phone as a live tool to solve in-field mechanical problems with thehelp from external consultants, engineers, etc. Stream and receive true real-timevideo while in-field to solve problems and collaborate.
Q-cast Civil services
Q-cast is also optimized for use by civil services, first responders, police, security,
etc. Using the mobile phone as the engine, connecting external cameras andother IoT devises used as wearables, ensures that the appropriate information isrevealed in true real-time to the correct people, at the right time from the rightangle. Thus, helping to make on-the-sport decisions, solve problems and create
solutions.
Q-cast Television

CONTACT INFOREGIONE VALLE D’AOSTAASSESSORATO FINANZE,ATTIVITA’ PRODUTTIVE,
ARTIGIANATO E POLITICHE
DEL LAVORO- Struttura Ricerca, Innovazione, Internazionalizzazione e
Qualità –www.regione.vda.it
f.clermont@regione.vda.it
T. +39 0165 274726
Fabrizio Clermont
SOC. QUINTETTO S.R.L.
Developments andtechnologies area
www.quintetto.it
giovanni.iamonte@quintetto.it
T. +39 393 9196310,
T. +39 0165 1845290,
Giovanni Iamonte36

Q-cast can also be used for real-time interactive television. Most recently Hewlett
Packard Enterprise launched its pTV powered by Quintetto for sales to television
stations globally. The solution can be bought directly from Quintetto or from HPE
globally. Fully tested in live environment and is the only streaming solution in
the world that provides real-time multi-camera streaming through its underlying
software platform, as opposed to using hardware.
Other uses for Q-cast includes, healthcare, citizen services, Know your customer
solutions, etc.
Technology
Q-cast utilizes the Quintetto’s proprietary platform, LETHO to compress data,
optimize routing and enable true real-time streaming from several cameras evenin poor network coverage. Said services are made available after 5 years of R&D
within streaming, traversal server, turn server and security. Letho has produced
products that have been awarded with the European Union seal of excellence.

BUSINESS OPPORTUNITY

We are looking for industrial and commercial partners to configure and propose
solutions in the civil and industrial fields for the various countries. Q-castaddresses issues such as civil protection, information, health, security and safety.
As for the industrial partners, our aim is to attract investments in our company,
starting from our plans.
We are also looking for financial investors to further our solutions on the global
market.

APULIA | D4D(Digital 4 Democracy)

1.2

Proposer: Cedat 85 srl
Sector: ICT

Focus:PROJECT DESCRIPTION

Cedat 85, innovative SME, is the leading company in Italy in providing content
from speech using advanced technologies.
Since the first half of the ‘90s, Cedat 85 has started, actively collaborating with
IBM, the research in the field of the automatic recognition of the voice speakerdependent (re-speaking), up to patent a system of live reporting, entirely
digital, that allows to eliminate all the equipment and media previously used:stenoterminali, dictaphones, recording plates, audio cassettes, coils and a system
for monitoring research, review, integration and audio / video / text editing
based on transcription of speech contained in multimedia sequences using
speech recognition and speech to text indexing systems. Moreover, thanks tothe continuous investments in R & D it has been possible to develop a “speakerindependent” recognition system for the Italian, German, French, English(UK), English (US), Spanish, Portuguese, Brazilian languages that can easily be
integrated with other foreign languages.
The company owns patents and registered Brands:
1. Patent n. 0001331981 – “Procedure to obtain simultaneous digital transcriptionof an oral exposure;
2. Patent n. 0001400352 “System for monitoring, researching, reviewing,
integrating and editing audio / video / text based on the transcription of
speech contained in multimedia sequences using speech recognition systems
and speech to text indexing”
3. Application for Patent n. 102017000145109 “Equipment for processing an
audio signal in writing”

CONTACT INFO

4. Brand n. 0001428130 – “TRASCRIVI”

PUGLIA SVILUPPO

5. Brand n. 0001428128 – “MAGNETOFONO”

www.pugliasviluppo.eu,
fdi@pugliasviluppo.eu

6. Brand n. 0001428131 – “+ VOCE”

T. +39 080.5498811

MAIN LINES OF PRODUCTS/SERVICES

Theresa Mulloy, Ewa Jankowska
Cedat 85 srl
cedat85@cedat85.com
T. +39 0831.952257
Enrico Giannotti – General
Managere.giannotti@cedat85.com
T. +39 348.1302376
Pierpaolo Barnaba – Sales& Marketing Manager
p.barnaba@cedat85.com
T. +39 348.2350321
Stefano Aldrovandi – Export
Managers.aldrovandi@cedat85.com
T. +39 335.6294928

7. Application for Brand n. 302018000013665 – “DIGITAL 4 DEMOCRACY”
1. Mediamonitor - monitoring of radio, TV and web programming
2. Digital 4 Democracy – Virtual Agora of political-administrative assemblies
aimed to encouraging transparency in institutions and the active participationof citizens
3. ADScribe – automatic verbalization system for Legal affairs and complianceoffices (Banks, Insurance companies)
4. + Voce – search system in multimedia content where each word is linked to themillisecond of video for Innovation Depts, System Integrators
5. BeSmartCall – monitoring system for call center, marketing dept, Customer
service operations

37

APULIA | D4D(Digital 4 Democracy)
Focus:

2.2

PROJECT
DIGITAL4DEMOCRACY is a highly powerful, advanced institutional communication
solution developed by Cedat 85 Group that facilitates open government and real
digital democracy through the automatic, real-time transcription and simultaneousarchiving of government speeches and meetings, making them accessible via
easily indexed and “searchable” digital content (accessible live as video is being
recorded), and making it easier for citizens to take an active part in democratic
life. The service has been lunched in Italy and abroad, in particular in the United
Kingdom, and used by 250 Italian and 120 foreign public administration.

BUSINESS OPPORTUNITY

Business/technology partners: the company has an interest in meeting realities
that develop applications with artificial intelligence and Bot, based on ASR
solutions.
The voice is the most used means of communication in the various sectors,
giving to the speaker recognition a leading role in the development of everyday
applications.
The application scenarios of ASR technologies are different:
1. the IOT sector (Internet of thinghs) that is literally exploding but at the sametime highlights problems both of simplicity of access (the voice is essential)
and of security (authorization of sending commands) as well as structure of theenvironment (smart home)
2. the banking / financial sector which on the one hand needs to simplify the lifeof its users and on the other to guarantee the necessary security
3. the call center sector in which “Virtual Assistants” could allow the use of themost advanced technologies in user interfaces as an innovative tool for the help
and simplification of the work of those working in companies or in the public
sector both in contact with customers and in the monitoring of activities and in
the analysis of market strategies

CONTACT INFOPUGLIA SVILUPPO
www.pugliasviluppo.eu
fdi@pugliasviluppo.eu
T. +39 080.5498811
Theresa Mulloy, Ewa Jankowska
Cedat 85 srl
cedat85@cedat85.com
T. +39 0831.952257
Enrico Giannotti – General
Managere.giannotti@cedat85.com
T. +39 348.1302376
Pierpaolo Barnaba – Sales& Marketing Manager
p.barnaba@cedat85.com
T. +39 348.2350321
Stefano Aldrovandi – Export
Managers.aldrovandi@cedat85.com
T. +39 335.6294928

38

4. the field of biometric technologies, advanced and intelligent integrated systems
that can replace complex password-based procedures, pins, cards and the likesometimes difficult to remember and often not available when needed, withbiometric identification technologies based on speech recognition technology,
capable of simplifying access to services, while ensuring - thanks to the use ofanti-spoofing technologies on the one hand and the artificial intelligence andthe Big-data on the other - the necessary level of privacy and safety

LAZIO | OLOS®

Proposer: BLUE CINEMA TV LTD. COMPANY
Sector: INTERACTIVE TECHNOLOGY

Focus:PROJECT DESCRIPTION
OLOS® is a procedure for creating an interactive audiovisual interface that
reproduces human beings. The OLOS® platform reaches it by changing theassumption that this is just a matter of engineering, and by leveraging a pragmaticand effective fusion of human creativity and state of the art technologies from IT
and digital cinematography. In OLOS®, human beings of flesh and blood supply
all the expressions and actions that the interfaces will use in their interaction withhuman users. They do so by playing parts and roles as in a performance. These
performances are then captured as sequences of images at very high visual output
through techniques of holographic simulation, and are deployed at the frontend of a highly distributed and interactive IT infrastructure, directly connectedto the cloud, and capable of linking users to all the available computational
and information resources. The resulting interfaces look and behave so humanthat it makes sense to refer to them as holographic human beings. OLOS®
anthropomorphic interfaces have already been deployed in a variety of real-life
contexts. The OLOS® platform is indeed evolutionary, and is compatible withvarious degrees of complexity and sophistication of the deployable interfaces.
Moreover, OLOS® manages the interactive communications through an artificial
intelligence system, contributing to a positive impact on the future of themethodology.

BUSINESS OPPORTUNITYCONTACT INFO
Daniele Baldacci
bluecinematv.com
info@bluecinematv.com
T. + 39 3393225424

Interfaces that reproduce perfectly the human expression and figure were so far
considered as a fundamentally unreachable goal; target that OLOS® has managed
to achieve. In fact, besides to perfectly reproducing the expression and the humanfigure, technology offers the opportunity to create a relationship between man
and technology by interactive and engaging. Aside the full user experience, it canbe used in many different situations such as Cultural Heritage, info points, learning
pathways and live entertainment. Moreover, it can be used to interact with users
when there is need for visual commercial demonstration, such as training, trying
on clothes and make-up session; thus offering consumers the security they needto purchase products through proofs and interactive simulations. Therefore, theopportunity offered by OLOS® is to arouse interest in the public, especially within
the sectors of Cultural Heritage and live shows, through a fruition of the service
increasingly interactive and less passive.

39

EMILIA-ROMAGNA | BIG DATATECHNOPOLE- BOLOGNA HUB

1.2

Proposer: REGIONE EMILIA-ROMAGNA
Sector: DIGITAL ECONOMY, SUPER COMPUTING, BIG DATA

Focus:PROJECT DESCRIPTION

The Big Data Technopole is located in the area of the “Former Tobacco Factory” in
Bologna, in a supportive business environment boasting a critical mass of research
centers and innovative companies.
The renovation project of the area has been selected through an internationalarchitecture competition.
In the same area will be located:• 4 of the 20 world most powerful HPC computers by 2020
• Innovative companies related to the sectors of the digital economy• the data centre of ECMWF (European Centre for Medium-Range Weather
Forecasts)• Cineca, an Inter-university consortium with supercomputer ranking first in the
EU as regards calculation systems for scientific research and Big Data
• Bi-Rex (Big Data Competence Center) involving 61 public and private
stakeholders, committed to connect Big Data to industry• other relevant national Research Centres: INFN (National Institute for Nuclear
Physics), ENEA (Italian National Agency for New Technologies, Energy andSustainable Economic Development), CINI (National Interuniversity Consortiumfor Informatics)
Emilia-Romagna is the first Italian region according to the Digital Economy andSociety Index and Bologna is the first Italian city in the Smart City Index (E&Y,
2016).
The region has:

CONTACT INFOERVET SpA Regional
Development Agency –Territorial Development andAttractiveness Unit
www.investinemiliaromagna.it
investinemiliaromagna@ervet.it
T. +39 051 6450417; +39 348
4216274 or +39 051 6450429;+39 347 3770319
Paola Maccani (Head); Sabino
Alvino (Expert)

42• a digital network for PA• a connection to the HS networks GARR/GEANT• about 1.800 researchers and 86 degree programmes in the field of digital
economy• 26 master degree programmes concerning Industry 4.0• a network of PPPs organized in specialized “Clust-ER”

EMILIA-ROMAGNA | BIG DATATECHNOPOLE- BOLOGNA HUB
Focus:

2.2

BUSINESS OPPORTUNITY

An area of about 40,000 sq.m of the Big Data Technopole in Bologna will beavailable for new investments:• 10,000 sq. m for new facilities to be built• 30,000 sq. m through renovation of already existing buildings (the five floors
building “Ballette”of 25,000 sq. m the “Salt Warehouse” of 5,000 sq. m suitablefor Conference Center)
Timing: a first area of 25,000 sq. m will be completed by 2021 (the area for
ECMWF by 2019).
Main targets for new investments:
Companies and public/private organizations and research centres in the sectors ofdigital economy, artificial intelligence, big data with applications in manufacturing,agrifood, life sciences, climate change, environmental protection, IP, Humanities,
Smart Cities; etc. ;International organizations (universities, research institutes, foundations, etc.);
International agencies/organizations (also with relationships with ECMWF);
Co-working and spin-off areas and conference centres;
Common services, spaces and security of the Technopole will be managed by aunique subject. Part of the energy supply will come from renewable resources.
Incentives could be provided.

CONTACT INFOERVET SpA Regional
Development Agency –Territorial Development andAttractiveness Unit
www.investinemiliaromagna.it
investinemiliaromagna@ervet.it
T. +39 051 6450417; +39 348
4216274 or +39 051 6450429;+39 347 3770319
Paola Maccani (Head); Sabino
Alvino (Expert)

43

FRIULI VENEZIA GIULIA | Additive
FVG Square
Proposer: FRIULI INNOVAZIONE
Sector: SMART MANUFACTURING

Focus:PROJECT DESCRIPTION

Additive FVG Square is an initiative launched by Friuli Innovazione - Research andTechnology Transfer Centre based in Udine. It is implemented in collaboration
with COMET - Friuli Venezia Giulia Metal Cluster, with the participation of the
University of Udine, in partnership with EOS and AM Ventures, and together withfive important regional companies (Brovedani Group, Cividale Group, SMS Group,
Thermokey and Wartsila).
Additive FVG Square is a SPACE OPEN TO COLLABORATION dedicated tothe development of skills of companies in the field of additive technologies. A
cutting-edge center, with a system for industrial 3D printing of metal parts, wherecompanies can learn and experience additive technologies in a concrete andmarket-oriented way.
Additive FVG Square represents the center of an ECOSYSTEM OF INTEGRATEDSERVICES FOR ADDITIVE MANUFACTURING (AM), where the actors of theinnovation and research system can learn, experiment and grow companies tomake them competitive in the changing scenario of global competition.

BUSINESS OPPORTUNITY
The BUSINESS OPPORTUNITY FOR FOREIGN COMPANIES is the possibility to behosted in the Science and Technology Park in Udine (where Additive FVG Squareis located) and be involved in the AM FVG ecosystem, which is characterized by:• an advanced university research laboratory in AM and virtual prototyping• a large manufacturing cluster with about four thousand companies• professional schools and technical institutes nationally known

CONTACT INFO

Autonomous Region of Friuli
Venezia Giulia – Central
Directorate for productive
activies and tourism - FVG
Investment Agency // Friuli
Innovazione Research andTechnology Transfer Centre
www.regione.fvg.it/rafvg/cms/
RAFVG/economia-imprese/;
www.investinfvg.it;
https://friulinnovazione.it/en/
https://additivefvg.it/en/
investinfvg@regione.fvg.it
saverio.deredita@friulinnovazione.it
T. +39 040/3772448
T. +39 040/3772423
T. +39 0432 629 928
Responsible: Central Director,
Antonio Bravo
Contact info: Rodolfo Martina
and Michela Masoch // Saverio
D’Eredità44• a leader enterprise in using AM technology• large manufacturing enterprises interested in developing AM• an industrial area offering infrastructures and services for companies
development

FRIULI VENEZIA GIULIA | Development ofa platform devoted to Artificial Intelligencefor manufacturing companies’ innovation
Proposer: Cluster of Digital Technologies (DITEDI)
Sector: SMART MANUFACTURING

Focus:PROJECT DESCRIPTION

The Region FVG – and the city of Udine in particular – aims to achieve a leadingrole in the development of Artificial Intelligence expertise and applications.
Significant investments in human capital and technological tools have been
already carried out in the past few months and many others have been planned,
especially for the realization of a “living lab” at the University of Udine. Firstly,
the living lab has the aim to connect the research world, ICT professionals andmanufacturing companies, for the research and development of “autonomousmachines” and systems, which will be capable of making independent decisions
on the basis of “machine learning”. Secondly, information and the latest
technological tools will be available for the companies, in order to support thedigital transformation processes of traditional SMEs.
The ultimate goal is the creation of an international reference center located in thespaces already identified and financed by MISE, MIUR and FVG Region, with theparticipation of the major regional research and technology-transfer agencies, thebusiness world and the ICT Cluster.
The public-private partnership is composed of the main regional stakeholders ofinnovation and digital transformation: the national research park ‘AREA Science
Park’; Science and Technology parks such as ‘Friuli Innovazione’ and ‘Polo
Tecnologico di Pordenone’; the University of Udine; ITS Malignani, Volta andKennedy (higher technical institutes); consortiums such as COSEF and Carnia
Industrial Park; the industrial associations Confindustria Udine and Assindustria
Pordenone; some important regional companies such as beanTech, InAsset,
Esteco, Eurotech, Teorema Engineering, ModeFinance and others.

CONTACT INFO
Autonomous Region of Friuli
Venezia Giulia – Central
Directorate for productive
activies and tourism - FVG
Investment Agency
DITEDI - Distretto Industrialedelle Tecnologie Digitali S.c.ar.l.
www.regione.fvg.it/rafvg/cms/
RAFVG/economia-imprese/;
www.investinfvg.it
www.ditedi.it
investinfvg@regione.fvg.it
segreteria@ditedi.it
T. +39 040/3772448
T. +39 040/3772423
T. +39 0432 1698013
Responsible: Central Director,
Antonio Bravo. Contact info:
Rodolfo Martina and Michela
Masoch // Francesco Contin,
Project manager DITEDIThe technological equipment of the “Artificial Intelligence and Data Analytics lab”
is being defined in agreement with the Department of Mathematics, Informatics
and Physics (DMIF) of the University of Udine.
Given the academic skills and the manufacturing and digital enterprises of thearea, with this project the Region of Friuli Venezia Giulia aspires to become aninternational point of reference on the AI subject, working on the production
system digitalization to aim for the realization of a “Manufacturing valley” 4.0.

BUSINESS OPPORTUNITY

The development of an international reference center of the Artificial Intelligencewithin the University of Udine area, providing additional resources to the initiatives
already launched by the greatest public and private stakeholders, in particularregarding the technological equipment of the already-under-construction living
lab located in the areas of the University of Udine. The living lab aims to become
the headquarter of the international center and to reach a level of excellencewith other partners, which would allow the international companies and researchorganizations to be engaged in its activities.
Thanks to the additional targeted investments there will be the chance to develop
further research and applications in this field, allowing the growth of regional
ICT companies and the digital transformation of local manufacturing companies.
This would permit them to stay world market leader in their industry and further
improve their competitive level, with resulting positive effects on both the whole
economic and social system of FVG Region.

45

LOMBARDY | MIND – Milano
Innovation District
Proposer: REGIONE LOMBARDIA
Sector:

DIGITAL: PROP-TECH, IOT, FIN-TECH, ARTIFICIAL INTELLIGENCE, CYBERSECURITY, AUGMENTED REALITY
SMART MOBILITYHEALTH INDUSTRY

Focus:PROJECT DESCRIPTION
Arexpo SpA is the owner of the 100 hectares site in Milan, located just a few miles
North-West of the city centre, which hosted the six-month Universal Expositionin 2015. Capitalising on the extraordinary success of this event, Arexpo SpA is
currently transforming the site into “MIND” a world-leading Science, Technology
and Innovation Park, a business friendly “innovation ecosystem” for domestic andinternational players, a “catalyst” for sustainable socio-economic growth, a new
vibrant community fully integrated with the city centre of Milan.
MINDlab is a call for non-binding expressions of interest regarding thedevelopment of field testing, experiments, pilot projects, applications, innovative
systems and technologies in a “living lab” environment.
The purpose of MINDlab is to create an ecosystem which fosters social innovation
processes, generating large-scale impact, for a better quality of urban life. The
deadline for the submission is the 31st of December 2018, 12:00 CET.

BUSINESS OPPORTUNITY

MIND concept: creating a place with a smart mix of people and public-private
stakeholders.
• a destination full of advantages and opportunities for world-class innovative
companies (national and multinational companies with innovative technologies,
solutions and products who require a physical test bed at urban scale),
universities and research institutes

CONTACT INFO

• a catalyst for responsible and sustainable socio-economic growth of local
communities and businesses

Arexpo – MIND1• expected daily population: 20.000 Students, 5.000 researchers, 30.000
workers, 2.000 residents and 10.000 visitors

www.mindmilano.it
www.arexpo.it• a new ecologically-sound urban area, with great infrastructure, fully integrated
with the city centre of Milan

mindlab@arexpo.it• potential for a mixed-use development totaling up to 480,000 square meters ofGross Floor Area

T. +39 02 69826768
Matteo Pirovano - Responsabile
Asset Management Arexpo• a vibrant community, high quality cultural activities, public realm, recreational
facilities• three major anchors: Human Technopole (a national cross-disciplinary research
infrastructure), Research and Treatment Hospital Galeazzi and the new scientific
Campus of University of Milan• 440.000 sqm of public realm and green infrastructure46

www.investinitaly.com

REGIONE PUGLIAForeign Direct Investment Department
Via Liszt, 21 - 00144 Rome, Italy
fdi@ice.it
www.ice.it
www.investinitaly.com